Zivo Bioscience (ZIVO, $16.97) was one of the top gainers for the month, rising +1 to $16.97 per share. A.I.dvisor analyzed 841 stocks in the Biotechnology Industry for the month ending May 12, 2025 and discovered that of them (7) exhibited an Uptrend while of them (2) exhibited a Downtrend. A.I.dvisor found 252 similar cases when ZIVO's price went up within one month. In out of those 252 cases, ZIVO's price went down during the next month. Based on these historical data, A.I. thinks the odds an Uptrend reversal for ZIVO are